These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18991483)

  • 21. Preparation and characterization of extruded magnetoliposomes.
    Sabaté R; Barnadas-Rodríguez R; Callejas-Fernández J; Hidalgo-Alvarez R; Estelrich J
    Int J Pharm; 2008 Jan; 347(1-2):156-62. PubMed ID: 17692483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo.
    Porter CD; Lukacs KV; Box G; Takeuchi Y; Collins MK
    J Virol; 1998 Jun; 72(6):4832-40. PubMed ID: 9573249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivo.
    Byun J; Huh JE; Park SJ; Jang JE; Suh YL; Lee JS; Gwon HC; Lee WR; Cosset FL; Kim DK
    J Gene Med; 2000; 2(1):2-10. PubMed ID: 10765500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
    Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell patterning using magnetite nanoparticles and magnetic force.
    Ino K; Ito A; Honda H
    Biotechnol Bioeng; 2007 Aug; 97(5):1309-17. PubMed ID: 17216656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
    Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
    J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
    Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
    Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of heterotypic cell sheets by magnetic force-based 3-D coculture of HepG2 and NIH3T3 cells.
    Ito A; Jitsunobu H; Kawabe Y; Kamihira M
    J Biosci Bioeng; 2007 Nov; 104(5):371-8. PubMed ID: 18086436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of magnetic cationic liposome in gene delivery.
    Zheng X; Lu J; Deng L; Xiong Y; Chen J
    Int J Pharm; 2009 Jan; 366(1-2):211-7. PubMed ID: 18848871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.
    Hagani AB; Rivière I; Tan C; Krause A; Sadelain M
    J Gene Med; 1999; 1(5):341-51. PubMed ID: 10738551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.
    von Rüden T; Stingl L; Cotten M; Wagner E; Zatloukal K
    Biotechniques; 1995 Mar; 18(3):484-9. PubMed ID: 7779400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
    J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force.
    Ito A; Ino K; Hayashida M; Kobayashi T; Matsunuma H; Kagami H; Ueda M; Honda H
    Tissue Eng; 2005; 11(9-10):1553-61. PubMed ID: 16259609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.
    Li KQ; Li WL; Peng SY; Shi XY; Tang HL; Liu YB
    Chin Med J (Engl); 2004 Sep; 117(9):1364-9. PubMed ID: 15377430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic magnetoliposomes.
    De Cuyper M; Soenen SJ
    Methods Mol Biol; 2010; 605():97-111. PubMed ID: 20072875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High efficiency and long-term foreign gene expression in cultured liver sinusoidal endothelial cells by retroviral transduction.
    Paez J; Montaño R; Benatuil L; Iacomini J; Cardier JE
    Endothelium; 2006; 13(4):279-85. PubMed ID: 16990184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
    Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
    Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.